Literature DB >> 19751347

Use of Chinese herbal medicine 'meizitanc' in pregnancy: report of three cases.

Filiz Cayan1, Umut Dilek, Esen Akbay, Ramazan Gen, Saffet Dilek.   

Abstract

The Chinese herbal medicine 'meizitanc', known as 'LiDa Dai Dai Hua Jiao Nang' (Kunming Dali Industry and Trade, Kunming, Yunnan, China) has been used by many women to support weight loss, even though life-threatening side-effects and deaths have been reported. We report the outcomes of three cases of exposure to 'meizitanc' during early pregnancy. In the first case, the pregnancy continued after the patient stopped taking the drug and at 38 weeks of gestation, the patient delivered a healthy infant. However, in the second and third cases fetal cardiac activities were not detected on obstetric follow-up and both pregnancies were terminated due to missed abortion. To our knowledge, this is the first report of exposure to meizitanc during pregnancy. Although herbal medicines are presumed to be safe because of their natural origin, consumption of such products may be dangerous due to the content of undeclared drugs, adulteration with multiple substances and contamination with toxic metals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751347     DOI: 10.1111/j.1447-0756.2008.01004.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  3 in total

1.  Traditional practices and adverse pregnancy outcomes in migrant women.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2016-12-12

2.  Complementary medicines in pregnancy: recommendations and information sources of healthcare professionals in Australia.

Authors:  Christine E Gilmartin; To-Hao Vo-Tran; Laura Leung
Journal:  Int J Clin Pharm       Date:  2018-02-23

3.  Herbal Medicines: Malaysian Women's Knowledge and Practice.

Authors:  Law Kim Sooi; Soon Lean Keng
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.